Immuron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum.

CEO

Steven Lydeamore

CEOSteven Lydeamore

Employees

—

Employees—

Headquarters

Carlton, Victoria (VIC)

HeadquartersCarlton, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRN Key Statistics

Market cap

14.64M

Market cap14.64M

Price-Earnings ratio

-5.57

Price-Earnings ratio-5.57

Dividend yield

—

Dividend yield—

Average volume

6.79K

Average volume6.79K

High today

$2.54

High today$2.54

Low today

$2.48

Low today$2.48

Open price

$2.54

Open price$2.54

Volume

5.23K

Volume5.23K

52 Week high

$5.96

52 Week high$5.96

52 Week low

$1.48

52 Week low$1.48

IMRN News

Yahoo Finance 18h

Immuron Director Resignation - Yahoo Finance

Immuron Limited MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated bi...

TipRanks 23h

Immuron Director Files Final Interest Notice - TipRanks.com - TipRanks

Immuron Limited (AU:IMC) has released an update. Stephen Anastasiou, a director at Immuron Limited, has filed a Final Director’s Interest Notice, disclosing hi...